SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patientArticle Published on 2022-09-012022-11-16 Journal: International Journal of Infectious Diseases [Category] [DOI] 10.1016/j.ijid.2022.06.023 PMC 바로가기
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab오크렐리주맙을 투여받는 다발성 경화증 환자의 말초 면역 세포 프로필과 관련된 SARS-CoV-2 백신 접종에 대한 면역 반응Article Published on 2022-09-012022-09-12 Journal: Journal of neurology, neurosurgery, and psychiatry [Category] [DOI] 10.1136/jnnp-2021-328197 PMC 바로가기 [Article Type] Article
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 백신 BNT162b2 또는 mRNA-1273 투여 후 면역저하 환자의 항체 반응: 무작위 대조 시험Randomized Controlled Trial Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac169 PMC 바로가기 [Article Type] Randomized Controlled Trial
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)광범위한 면역 손상 조건에 걸친 코로나바이러스 질병 2019(COVID-19) 백신 반응의 전향적 평가: 면역 손상 연구(COVICS)의 COVID-19 백신 접종Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac103 PMC 바로가기 [Article Type] Article
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile칠레의 면역 저하 환자 집단에서 비활성화된 중증 급성 호흡기 증후군 코로나바이러스 2 백신에 대한 면역 반응 감소Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac167 PMC 바로가기 [Article Type] Article
Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patientsCase report Published on 2022-08-232022-10-05 Journal: IDCases [Category] [DOI] 10.1016/j.idcr.2022.e01611 [Article Type] Case report
Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular LymphomaArticle Published on 2022-08-152022-11-15 Journal: Internal medicine (Tokyo, Japan) [Category] [DOI] 10.2169/internalmedicine.9136-21 PMC 바로가기
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis면역저하 집단에서 SARS-CoV-2 백신의 1차, 2차, 3차 접종 후 혈청전환: 체계적인 검토 및 메타분석Review Published on 2022-08-082022-09-12 Journal: Virology Journal [Category] [DOI] 10.1186/s12985-022-01858-3 PMC 바로가기 [Article Type] Review
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings다양한 임상 환경에서 면역 저하 환자의 오미크론 변이체에 대한 동형 및 이형 면역 반응Article Published on 2022-08-042022-09-11 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-022-32235-x PMC 바로가기 [Article Type] Article
Patients with CLL have a lower risk of death from COVID-19 in the Omicron eraCLL 환자는 오미크론 시대에 COVID-19로 인한 사망 위험이 더 낮습니다Article Published on 2022-08-042022-09-11 Journal: Blood [Category] [DOI] 10.1182/blood.2022016147 PMC 바로가기 [Article Type] Article